01 January 2015

Treatment Algorithm for PAH

Mathier {MA},Stamm {JA},Risbano {MG}.Overview of current therapeutic approaches for pulmonary hypertension. [Internet]. 2011 ;1:138. Available from:http://www.pulmonarycirculation.org/text.asp?2011/1/2/138/83444

Treatment Algorithm for PAH. Lower risk PAH constitutes those patients with no evidence of right heart failure, WHO II or III functional status, preserved 6MWD and minimally elevated natriuretic peptide levels. Higher risk PAH patients have clinical or hemodynamic evidence of right heart failure, WHO class IV functional status, short 6MWD or significantly elevated natriuretic peptide levels. (6MWD: six-minute walk distance; FC: functional class; CCB: calcium channel blocker; ETRA: endothelial receptor antagonist; PAH: pulmonary arterial hypertension; PDE5: phosphodiesterase 5 inhibitor; RHC: Right heart catheterization; TTE: transthoracic echocardiogram; WHO: World Health Organization).


Additional keywords: diagnosis,WHO,classification

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI